Eric Kelsic, Dyno Therapeutics CEO

Dyno's Er­ic Kel­sic fills the tank in his quest for bet­ter AAV with a group of big-name sup­port­ers on board

Ade­no-as­so­ci­at­ed virus­es (AAV) for gene ther­a­py have re­ceived a ton of scruti­ny through­out the field’s his­to­ry af­ter a smat­ter­ing of safe­ty scares and their lim­it­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA